O’Malley Gets Six-Month Suspension, Cleared for UFC 248

Sean O’Malley will finally get the chance to return to the Octagon, with the resolving of his run-ins with USADA clearing the path for a return at UFC 248 in March.

After a series of failed drug tests and an extensive defense and investigation, O’Malley has agreed to a six-month suspension, retroactive to August. As a result, a bout between him and Jose Quinonez is now locked in for UFC 248.

The bout was scheduled for UFC 247 next month but is assumed to have been pushed back in an effort to ensure O’Malley’s clearing. He last competed almost exactly two years to the date of his next fight, defeating Andre Soukhamthath at UFC 222.

“O’Malley, 25, tested positive for ostarine as the result of out-of-competition urine samples he provided on August 6, 2019 and August 12, 2019,” USADA officials announced in a statement. “His two positives, as well as additional positives collected after August 12, 2019, were treated as a single violation because the estimated concentration of ostarine in the urine samples was consistent with ingestion prior to August 29, 2019, the date O’Malley received notification of his second violation.

“In addition, the pattern of low urinary ostarine concentrations observed in multiple samples provided by O’Malley was consistent with exposure to ostarine as a contaminant.”

O’Malley was scheduled to compete at UFC 229 in October 2018 but was pulled from the card and given a six-month ban after testing positive for ostarine, which was ultimately linked to a supplement. He was flagged again for ostarine in late June, forcing him out of UFC 239 and being given another ban. The out-of-competition samples O’Malley then provided in August showed traces of ostarine.

According to USADA (United States Anti-Doping Agency), O’Malley submitted to extensive testing, continued to monitor his supplements, kept food logs and eventually he was cleared of intentionally ingesting any performance-enhancing substances.

Original Story: MMA Fighting

You might also like
By using our site you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Service. X